IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v7y2016i1d10.1038_ncomms13513.html
   My bibliography  Save this article

Correction: Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients

Author

Listed:
  • Jacob J. Chabon
  • Andrew D. Simmons
  • Alexander F. Lovejoy
  • Mohammad S. Esfahani
  • Aaron M. Newman
  • Henry J. Haringsma
  • David M. Kurtz
  • Henning Stehr
  • Florian Scherer
  • Chris A. Karlovich
  • Thomas C. Harding
  • Kathleen A. Durkin
  • Gregory A. Otterson
  • W. Thomas Purcell
  • D. Ross Camidge
  • Jonathan W. Goldman
  • Lecia V. Sequist
  • Zofia Piotrowska
  • Heather A. Wakelee
  • Joel W. Neal
  • Ash A. Alizadeh
  • Maximilian Diehn

Abstract

Nature Communications 7: Article number: 11815 (2016); Published 10 June 2016; Updated 14 November 2016 Previous work by Del Re et al. describing the emergence of KRAS mutations following treatment of non-small cell lung cancer patients with EGFR tyrosine kinase inhibitors was inadvertently omitted from the reference list of this Article and should have been cited as follows.

Suggested Citation

  • Jacob J. Chabon & Andrew D. Simmons & Alexander F. Lovejoy & Mohammad S. Esfahani & Aaron M. Newman & Henry J. Haringsma & David M. Kurtz & Henning Stehr & Florian Scherer & Chris A. Karlovich & Thoma, 2016. "Correction: Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients," Nature Communications, Nature, vol. 7(1), pages 1-1, December.
    • Handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms13513
    DOI: 10.1038/ncomms13513
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms13513
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/ncomms13513?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Lavinia Tan & Chris Brown & Antony Mersiades & Chee Khoon Lee & Thomas John & Steven Kao & Genni Newnham & Kenneth O’Byrne & Sagun Parakh & Victoria Bray & Kevin Jasas & Sonia Yip & Stephen Q. Wong & , 2024. "A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE," Nature Communications, Nature, vol. 15(1), pages 1-13, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms13513. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.